News and Trends 4 Apr 2018 Placebo Beats a Gene Therapy for Blindness in a Phase 3 Trial GenSight has demonstrated that its gene therapy for a rare disease causing blindness can significantly improve the vision of patients. But so does the placebo. GenSight Biologics has released the results of a Phase III clinical trial testing its gene therapy GS010 in patients suffering from Leber hereditary optic neuropathy (LHON), a rare mitochondrial disease […] April 4, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 3 Apr 2018 Cheese-Producing Bacteria Could Help Reverse Type 1 Diabetes ActoBio Therapeutics has received permission from the FDA to start a clinical trial for a type 1 diabetes treatment that uses a bacterial strain also used in cheese production. After being cleared by the FDA, ActoBio, based in Belgium, plans to begin a PhaseIb/IIa study for its drug, AG019, to treat early-onset type 1 diabetes. What makes […] April 3, 2018 - 2 minutesmins - By Editorial Team Share WhatsApp Twitter Linkedin Email
Interview 3 Apr 2018 Seven Expert Tips on How to Grow a Successful Biotech Startup The journey to create and grow a successful biotech startup is long and carries a high risk of failure. I decided to explore the main pitfalls that biotech entrepreneurs find and how to avoid them. Biotech startups can bring solutions to some of the biggest problems in the world, making some bucks along the way. […] April 3, 2018 - 8 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Infographics 2 Apr 2018 Infographic: All You Need to Know About Cultured Meat You might have heard about a new type of meat that can be produced without harming animals or harming the environment. This infographic will show you everything you need to know about cultured meat, which might be on your plate sooner than you think. In the not-so-distant future, the vegan diet might include meat. Researchers […] April 2, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Startup Scout 30 Mar 2018 This French Biotech Detects Microbes With a “Molecular Hook” Today we are in the sunny Marseille, on the South coast of France, visiting Click4Tag, a biotech developing a molecular hook to attach to and detect microbial membranes. Its unusual principle has both environmental and medical applications. Mission: Founded in 2014, Click4Tag is developing a unique technology to detect microorganisms. The company introduces a “molecular hook” into […] March 30, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 29 Mar 2018 Cancer Trial Halted in the UK After Overdosing First Patient Redx Pharma has temporarily interrupted recruitment in a Phase I/IIa cancer trial following “significant adverse events” of its drug on the first patient treated. The first time Redx Pharma’s cancer drug RXC004 has been tested in a patient has resulted in adverse side effects. According to Redx, the dose tested resulted in a higher exposure […] March 29, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 29 Mar 2018 What Are the Best Funding Strategies for Biotech Startups? Funding a biotech startup is no easy task and can influence the long-term success of a company. Here are some of the do’s and don’ts of successful biotech fundraising. Learning from failures can be valuable in almost any pursuit, and biotech funding strategies are no exception. For example, when a startup is in the initial stages of […] March 29, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 28 Mar 2018 AI Is Being Put to Work to Treat Parkinson’s Disease in the UK The artificial intelligence company BenevolentAI is collaborating with two UK charities to use AI to identify ideal drug candidates for treating Parkinson’s disease. BenevolentAI, Europe’s largest private AI company, is collaborating with Parkinson’s UK and The Cure Parkinson’s Trust (CPT), two UK charities, to repurpose at least three existing drugs and identify two novel drug targets […] March 28, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 27 Mar 2018 A New Liquid Biopsy Can Improve Ovarian Cancer Diagnosis Angle, a UK-based biotech, is developing a non-invasive liquid biopsy that could be better than current diagnostic methods at predicting ovarian cancer. Angle, a company specializing in liquid biopsies, has shown that its Pelvic Mass Triage (PMT) liquid biopsy test can differentiate between benign and cancerous pelvic masses and ovarian cysts in 95% of cases […] March 27, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 27 Mar 2018 Stem Cell Therapy for Crohn’s Disease Approved in Europe Developed by TiGenix, Alofisel is the first stem cell therapy made out of donor stem cells to receive a marketing authorization in Europe. The European Commission has approved Alofisel (darvadstrocel), a stem cell therapy to treat complex perianal fistulas — one of the most disabling complications of Crohn’s disease. The cell therapy represents an alternative to multiple surgeries […] March 27, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 26 Mar 2018 Attacking an Ancient Virus Slows Multiple Sclerosis in Phase II GeNeuro has released Phase IIb data showing that its antibody can reduce brain damage in patients with multiple sclerosis by going after an unusual target: a virus that has been in our genome since ancient times. Paris-based biotech GeNeuro has reported that a treatment it is developing in partnership with Servier has potential to treat […] March 26, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 26 Mar 2018 New Antibiotic for Urinary Tract Infections Gets Positive Phase II Results Allecra Therapeutics has obtained positive Phase II study results for its new urinary tract infection antibiotic, supporting the launch of a Phase III trial. Allecra Therapeutics, a French-German biotech, has obtained positive Phase II trial results for its lead antibiotic candidate for treating urinary tract infections. The drug, AAU101, was given to patients intravenously with cefepemine, another antibiotic […] March 26, 2018 - 1 minutemin - By Alexander Burik Share WhatsApp Twitter Linkedin Email